I'm LongbridgeAI, I can summarize articles.The Week
Credo Tech fell 24.07% this week to close at $99.86, while the S&P 500 dropped 8.61%, leaving the stock about 15.46 percentage points behind the benchmark. The shares spent the first four sessions trading between $118 and $131, hit a weekly high of $131.15 on Thursday, then pulled back sharply. Friday saw a gap lower and a slide to $97.92 on heavy volume of roughly 13.2m shares, closing near the low of the week. The pattern was a late-week break to the downside, with a weekly range of 27.1%.
Key Events
Two stories ran through the week: broad pressure on AI chip names, and Credo’s own patent settlement with Marvell. On Wednesday the companies reached a patent agreement, and Credo rose during the session and gained more than 8% after hours. On Thursday, commentary suggested the settlement might change the investment case for Credo and that the stock could be undervalued. On Friday, Stifel kept its buy rating but cut its target to $250 from $310. Over the weekend, reports said chip stocks lost $2.3 trillion in market value for the week as anxiety spread through the AI trade, with Credo’s decline tracking the sector.
Analyst Ratings
As of 20 November 2026, 20 brokers cover Credo Tech: 14 rate it buy, 5 rate it overweight, and 1 rates it hold, with no sell or underweight ratings. The consensus rating is strong buy, and the consensus target of $274.31 sits about 174.7% above the latest price of $99.86. Individual targets range from $175 to $315, a wide dispersion. Credo ranks 19th among 78 semiconductor names in its industry group.
The Week Ahead
Two sets of data are worth tracking. On Tuesday the US releases FHFA home prices, the Case Shiller 20-city index, consumer confidence, and the Richmond Fed composite. Those readings may shape rate and risk appetite expectations. Credo itself reports fiscal Q2 2027 results after the market close on 1 December, with consensus at $0.82 EPS and $532m in revenue.
In Short
Broker ratings remain heavily skewed toward buy and overweight, and the consensus target is more than double the current share price, so the ratings picture skews positive. But the stock fell on heavy volume this week, and the latest session shows net selling from large and medium orders while smaller orders lean the other way, a fragile flow setup. AI sentiment is cooling fast, tying Credo’s recovery prospects to the sector’s risk appetite. The next tests are whether the patent settlement translates into fundamentals, and whether the early-December earnings validate growth expectations.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
